跳至主要内容
临床试验/NCT02804087
NCT02804087终止不适用

CALM-START - Controlling And Lowering Blood Pressure With the MobiusHDTM Device: STudying Effects in A Randomized Trial

Vascular Dynamics, Inc.8 个研究点 分布在 1 个国家目标入组 4 人开始时间: 2017年8月24日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
4
试验地点
8
主要终点
The change in mean systolic 24-hour ABP from baseline to 90 days post-randomization, between the treatment arm and the sham arm.

研究概览

简要总结

To evaluate the safety and performance of the MobiusHD system in subjects with resistant hypertension.

详细描述

This is a prospective, randomized, double-blind, sham-controlled, multi-center post market study investigating the efficacy and safety of MobiusHD System, and the efficacy of the MobiusHD device in lowering mean systolic 24-hour ABP in subjects with resistant hypertension.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Aged 18-70 years;
  • Diagnosed with resistant hypertension;
  • A mean systolic 24-hour ABP of 135-170 mmHg following at least 30 days on a stable antihypertensive medication regimen (no changes in medications or dose).
  • A mean systolic 24-hour ABP of 135-170 mmHg after washout of all antihypertensive medications.

排除标准

  • Known or clinically suspected baroreflex failure or autonomic neuropathy
  • Treatable cause of resistant hypertension
  • Hypertension secondary to an identifiable and treatable cause other than sleep apnea

结局指标

主要结局

The change in mean systolic 24-hour ABP from baseline to 90 days post-randomization, between the treatment arm and the sham arm.

时间窗: From Baseline to 90 days post-randomization

Reduction in mean systolic 24-hour ABP

次要结局

  • Major adverse clinical events, including death, stroke, carotid interventions, and myocardial infarction, from baseline to 30 days post-randomization, between the treatment arm and the sham arm.(From Baseline to 30 days post-randomization)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (8)

Loading locations...

相似试验

Controlling And Lowering Blood Pressure With the... | 临床试验